Press Releases for Austria
Bluefin Acquires TECS to Combine Payments and Data Security Solutions
Bluefin and TECS’ combined technologies will help meet increased global demand for secure omnichannel payments 01/11/2022 — ATLANTA & VIENNA — (BUSINESS WIRE) Bluefin, the recognized integrated payments leader in […]
Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System
People with diabetes in the United Kingdom, Ireland, Germany, Austria and Hong Kong can get started with Dexcom G7 now The new CGM system is also expected to launch in […]
Global Summit Ends With One Million Rally of Hope and Renewed Calls for Unity on the Korean Peninsula
16/02/2022 — VIENNA & WASHINGTON D.C. — (BUSINESS WIRE) The World Summit 2022 (Summit for Peace on the Korean Peninsula) ended its third day with global encouragement, practical advice and […]
Slate Asset Management Continues Its European Expansion with Approximately €90.0 Million Essential Real Estate Portfolio Acquisition in Austria and Slovakia
22/11/2021 — LONDON & FRANKFURT, Germany — (BUSINESS WIRE) Slate Asset Management (“Slate”), a global alternative investment platform focused on real estate, announced today the acquisition of a portfolio of […]
Hanshow Announces New AI Camera-Driven Solutions in China Developed in Collaboration With Microsoft and Sony Semiconductor Solutions
08/11/2021 — SHANGHAI — (BUSINESS WIRE) At the 2021 China International Import Expo (CIIE), Hanshow has announced a commercial AI camera-driven retail solution, developed through a collaboration with Microsoft and […]
INNIO Jenbacher is Offering Off-Grid Solutions to Help Drive the Transformation to Electromobility
INNIO Jenbacher is Offering Off-Grid Solutions to Help Drive the Transformation to Electromobility INNIO Jenbacher offers solutions for off-grid stationary charging stations Jenbacher gas engines portfolio is “Ready for H2” […]
UNIVERSAL PEACE FEDERATION: World Leaders Renew Call for Peace on the Korean Peninsula During Rally of Hope Showcase of Think Tank 2022
14/09/2021 — VIENNA — (BUSINESS WIRE) World leaders and experts renewed their calls for peaceful reconciliation on the Korean Peninsula during the virtual Rally of Hope September 12 (KST). The […]
INNIO Joins United Nations Global Compact Further Underscoring Commitment to Sustainability
INNIO joins more than 9,500 companies and 3,000 non-business signatories to support UN goals and issues INNIO joins United Nations Global Compact as part of continued pursuit to achieve climate-neutral […]
Comcast Announces Peacock Coming to Sky
Later This Year, Nearly 20 Million Sky Customers In UK, Ireland, Germany, Italy, Austria, and Switzerland Will Receive Peacock at No Extra Cost with Sky Q, NOW, and Sky Ticket […]
McKesson Corporation Enters Agreement to Sell Certain European Businesses to the PHOENIX Group
Transaction enhances McKesson’s focus and commitment to future investments in strategic growth, including oncology and biopharma services, and core pharmaceutical and medical distribution Agreement includes the sale of McKesson Europe […]
Kwizda Agro Speeds up Its Packaging Process With Fabasoft Approve
A central data environment for efficient workflows and greater planning reliability 10/06/2021 — LINZ, Austria — (BUSINESS WIRE) Kwizda Agro, a leading provider of crop protection products, is digitalizing its […]
Schwarzmüller Group Relies on Fabasoft Approve For Resilient Supply Chain Management
A cloud-based supplier portal with instant ERP-system integration 31/03/2021 — LINZ, Austria — (BUSINESS WIRE) Commercial vehicle manufacturer Schwarzmüller digitalizes its communication with suppliers and adopts paperless order processing. A […]
Speech Processing Solutions: Next-generation workflow solution with AI-powered speech recognition
Philips Dictation and Nuance expand their long-standing partnership with SpeechExec Enterprise 7.0 15/10/2020 — VIENNA — (BUSINESS WIRE) The new version of the Philips dictation workflow solution for enterprise businesses, […]
TELUS International to Acquire Competence Call Center
Merger adds significant scale, enhances its digitally-integrated solutions portfolio, and expands its European presence An elevated enterprise value of approximately US$3.8 billion positions TELUS International for a future initial public […]
Austrian Tom Sipos Crowned elit® Vodka Art of the Martini Global Winner
Bartender from Vienna created the most avant-garde martini at this year’s competition, hosted in Bilbao ahead of The World’s 50 Best Restaurants 20/06/2018 — BILBAO, Spain — (BUSINESS WIRE) After […]
Another Victory for SPI in Stolichnaya Trademark Dispute
16/02/2018 — LINZ, Austria — (BUSINESS WIRE) On February 5, 2018, in Linz, SPI Group achieved yet another significant legal victory in its long-running dispute with Russian state-owned entity Federal […]
Samsung Electronics and TTTech Announce Strategic Partnership to Deliver Next Generation of Autonomous and Safety Technology to Automakers
Samsung to join AUDI AG as a major investor in TTTech, which will develop new open-innovation platform for ADAS/AV systems; HARMAN to integrate this open platform offering to its innovative […]
MSD Animal Health to Purchase Manufacturing Facility in Krems, Austria
European Facility Will Boost Global Vaccine Production Capacity 08/08/2017 — MADISON, N.J. — (BUSINESS WIRE) MSD Animal Health, known as Merck Animal Health in the United States and Canada, today […]
Physio-Control Launches LIFEPAK® CR2 Defibrillator
New LIFEPAK AED Response System Offers Connectivity, Intuitive Design and Unique Technology to Analyse Heart Rhythm during CPR New AED Solution to be Exhibited at MEDICA 2016, November 14-17 02/11/2016 […]
UniCredit Bank Austria, Raiffeisen Bank International and UniCredit Bulbank Granted an Expanded € 112.9 Million Senior Facility to Business Park Sofia
20/10/2016 — VIENNA, Austria & SOFIA, Bulgaria — (BUSINESS WIRE) UniCredit Bank Austria AG and UniCredit Bulbank AD increased and amended its current senior facility with Business Park Sofia (BPS), […]
New Data from KEYNOTE-028, MSD’s Trial Evaluating KEYTRUDA® (pembrolizumab) Across a Range of Cancer Types, Presented at 2015 European Cancer Congress
MSD, known as Merck (NYSE:MRK) in the United States and Canada, today announced new findings from the KEYNOTE-028 Phase 1b study, the clinical trial investigating the use of the company’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab) in multiple, difficult-to-treat cancers. Data from this trial, to be presented at the European Cancer Congress (ECC) in Vienna, Austria, Sept. 25-29, include the first-time findings for KEYTRUDA in two gastrointestinal cancers, advanced anal cancer and advanced biliary tract cancer, and add to MSD’s growing body of clinical data for KEYTRUDA.
New Findings Show Anti-Tumor Activity of KEYTRUDA® (pembrolizumab) in Patients with Advanced Nasopharyngeal Carcinoma
MSD, known as Merck (NYSE:MRK) in the United States and Canada, today announced the first-time presentation of findings investigating the use of KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, as a monotherapy in patients with advanced unresectable nasopharyngeal carcinoma (NPC) – a type of head and neck cancer – whose tumors express PD-L1 (≥1% of cells in tumor nests or PD-L1+ bands in stroma). Data were from a Phase 1b study (KEYNOTE-028) and showed an overall response rate (ORR) (confirmed and unconfirmed) of 22.2 percent (95% CI, 8.6-42.3) in evaluable patients (n=27) who were treated with KEYTRUDA. Results were presented in an oral session by Dr. Chiun Hsu, National Taiwan University Hospital, at the European Cancer Congress (ECC) in Vienna (Abstract #2801).
CEMEX Announces Divestment of Its Operations in Austria and Hungary
CEMEX, S.A.B. de C.V. (CEMEX) (NYSE: CX) announced today that it has signed an agreement for the sale of its operations in Austria and Hungary to the Rohrdorfer Group for approximately 160.1 million.
UniCredit Bank Austria and UniCredit Bulbank Provide 103.3 Million Senior Facility to Business Park Sofia
UniCredit Bank Austria AG and UniCredit Bulbank AD have jointly underwritten a 103.3 million senior facility to refinance Business Park Sofia (BPS), the largest office park in Southeastern Europe. The transaction closed in June 2015.
MSDs Pivotal Phase 3 C-EDGE Programme Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses Across Broad Range of Patients with Chronic Hepatitis C Virus Infection
MSD, known as Merck (NYSE:MRK) in the United States and Canada, announced today the first presentations of data from the companys ongoing C-EDGE pivotal Phase 3 clinical trial programme evaluating the investigational once-daily tablet grazoprevir/elbasvir (100mg/50mg) in patients with or without cirrhosis who are infected with chronic hepatitis C virus (HCV) genotypes 1, 4 or 6 (GT1, 4 or 6).1 Patients in both the HCV infected, treatment-naïve (C-EDGE TN), and HIV/HCV co-infected, treatment-naïve (C-EDGE CO-INFXN) trials treated for 12 weeks achieved rates of sustained virologic response 12 weeks after the completion of treatment (SVR12) of 95 percent (299/316 and 207/218, respectively). In addition, HCV infected, treatment-experienced patients (C-EDGE TE) treated with or without ribavirin (RBV) for 12 weeks achieved SVR12 rates of 94 percent (98/104) and 92 percent (97/105), respectively, and those treated for 16 weeks achieved SVR12 rates of 97 percent (103/106) and 92 percent (97/105), respectively. These data were presented at The International Liver CongressTM 2015 the 50th annual congress of the European Association for the Study of the Liver (Abstract #G07, E-Poster P0886 and E-Poster P0887). A paper detailing the findings of C-EDGE TN was published online in the Annals of Internal Medicine today.
MSD Announces Results from Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
MSD, known as Merck (NYSE:MRK) in the United States and Canada, today announced the first presentation of data from C-SURFER, the companys Phase 2/3 clinical trial evaluating the investigational once-daily treatment regimen of grazoprevir (100mg) and elbasvir (50mg) in patients with advanced chronic kidney disease (CKD) infected with chronic hepatitis C virus (HCV) genotype 1 (GT1).1 Treatment-naïve patients and patients who failed prior pegylated interferon HCV therapy, with or without cirrhosis, all of whom had CKD stages 4 or 5, were enrolled.2 Following 12 weeks of treatment with grazoprevir and elbasvir, 99 percent (115/116) of patients in the pre-specified primary population for analysis of efficacy data achieved a sustained virologic response 12 weeks after the completion of treatment (SVR12).3 These data will be presented today at The International Liver CongressTM 2015 the 50th annual congress of the European Association for the Study of the Liver (late breaking E-Poster #LP02).
Victorias Secret and Swarovski Sparkled at Their London Debut
For nearly 120 years, Swarovski has inspired creative talents from the world of fashion, jewelry, accessories, interior design and lighting with its brilliant crystal innovations. It seeks to push the boundaries of creativity and to bring the sparkling glamour of crystal to designer and consumer alike. Since 2002, Swarovski has exclusively provided dazzling crystals to adorn costumes and jewelry of the most glamorous events on the fashion calendar, including the Victorias Secret Fashion Show. This celebrated catwalk extravaganza is where lingerie, and couture meet, as the world’s most beautiful modelsknown as Victorias Secret Angelsblaze a trail down the runway.
New Study Shows Magnetic Implant is an Important Break-Through in the Treatment of Reflux Disease
Torax Medical announced today the publication of new data comparing the LINX Magnetic Sphincter Augmentation Device and laparoscopic fundoplication surgery in 249 patients. Data from this study significantly adds to the growing body of evidence that the LINX device is a safe and effective procedure for patients suffering from gastro-esophageal reflux disease (GERD). Current surgical options (fundoplication) require the patients stomach tissue to be wrapped around the esophagus to create a barrier to reflux. The LINX device provides protection from reflux without compromising the patients stomach while minimizing the side effects commonly associated with the present surgical approaches.
MSD Presents First Phase 3 Data in Japanese Patients for Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes
MSD, known as Merck & Co., Inc. (NYSE:MRK) in the United States and Canada, today announced the presentation of the first data from the Phase 3 clinical development program for omarigliptin, MSDs investigational once-weekly DPP-4 inhibitor for the treatment of type 2 diabetes. In a study in Japanese patients, omarigliptin provided comparable efficacy and tolerability to MSDs once-daily DPP-4 inhibitor, JANUVIA (sitagliptin) 50 mg, which is the standard starting dose for sitagliptin in Japan.1 MSD presented these data on omarigliptin, which has been shown to produce sustained DPP-4 inhibition, at an oral session at the 50th European Association for the Study of Diabetes (EASD) Annual Meeting.
ToysRUs, Inc. Strengthens Global E-Commerce Presence with Launch of Dedicated Web Store in China, Mobile Shopping Capabilities Introduced in Additional International Markets
ToysRUs, Inc. today announced it has strengthened its global e-commerce capabilities with the launch of a dedicated web store, Toysrus.com.cn, in China. The addition of this site represents a significant step in the companys plans to grow its presence with physical stores and online operations in Asia. The company has also announced the development of mobile-optimized sites and apps in 11 markets around the world, including Australia, Canada, France, Germany, Japan, Spain, and the U.K. In the coming months, it will introduce the same capabilities in Portugal, Austria and Switzerland, as well as the Netherlands, where it does not currently have a store presence.